Helsinn Healtcare S.A. v. Teva Pharm. USA, Inc.

139 S. Ct. 358, 202 L. Ed. 2d 216
CourtSupreme Court of the United States
DecidedOctober 9, 2018
DocketNo. 17–1229.
StatusPublished

This text of 139 S. Ct. 358 (Helsinn Healtcare S.A. v. Teva Pharm. USA, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Helsinn Healtcare S.A. v. Teva Pharm. USA, Inc., 139 S. Ct. 358, 202 L. Ed. 2d 216 (U.S. 2018).

Opinion

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
139 S. Ct. 358, 202 L. Ed. 2d 216, Counsel Stack Legal Research, https://law.counselstack.com/opinion/helsinn-healtcare-sa-v-teva-pharm-usa-inc-scotus-2018.